- Home
- ZLAB
ZLAB
Zai Lab Limited
as of 12-05-2025 3:45pm EST
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
| Founded: | 2013 | Country: | China |
| Employees: | N/A | City: | SHANGHAI |
| Market Cap: | 2.2B | IPO Year: | 2017 |
| Target Price: | $57.22 | AVG Volume (30 days): | 849.1K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.92 | EPS Growth: | N/A |
| 52 Week Low/High: | $19.40 - $44.34 | Next Earning Date: | 11-06-2025 |
| Revenue: | $441,629,000 | Revenue Growth: | 24.14% |
| Revenue Growth (this year): | 30.2% | Revenue Growth (next year): | 34.71% |
AI-Powered ZLAB Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Zai Lab Limited (ZLAB)
Chief Legal Officer
Avg Cost/Share
$19.78
Shares
14,328
Total Value
$283,407.84
Owned After
27,737
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$26.83
Shares
240
Total Value
$6,439.44
Owned After
17,444
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$34.25
Shares
456
Total Value
$15,616.63
Owned After
17,444
SEC Form 4
See Remarks
Avg Cost/Share
$28.91
Shares
10,000
Total Value
$289,100.00
Owned After
86,604
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Edmondson Frazor Titus III | ZLAB | Chief Legal Officer | Nov 21, 2025 | Sell | $19.78 | 14,328 | $283,407.84 | 27,737 | |
| Chen Yajing | ZLAB | Chief Financial Officer | Nov 3, 2025 | Sell | $26.83 | 240 | $6,439.44 | 17,444 | |
| Chen Yajing | ZLAB | Chief Financial Officer | Oct 2, 2025 | Sell | $34.25 | 456 | $15,616.63 | 17,444 | |
| Smiley Joshua L | ZLAB | See Remarks | Sep 10, 2025 | Buy | $28.91 | 10,000 | $289,100.00 | 86,604 |
Compare ZLAB vs Leading Stocks
See how ZLAB stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ZLAB Zai Lab Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.